Unique Wealth LLC bought a new stake in shares of Genpact Limited (NYSE:G - Free Report) in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 6,556 shares of the business services provider's stock, valued at approximately $330,000.
Several other large investors have also modified their holdings of G. Norges Bank purchased a new position in shares of Genpact during the fourth quarter valued at approximately $90,516,000. Tandem Investment Advisors Inc. boosted its position in shares of Genpact by 390.5% during the fourth quarter. Tandem Investment Advisors Inc. now owns 2,129,915 shares of the business services provider's stock valued at $91,480,000 after buying an additional 1,695,706 shares during the period. Victory Capital Management Inc. boosted its position in shares of Genpact by 18.1% during the fourth quarter. Victory Capital Management Inc. now owns 9,853,437 shares of the business services provider's stock valued at $423,205,000 after buying an additional 1,511,790 shares during the period. Lord Abbett & CO. LLC purchased a new position in shares of Genpact during the fourth quarter valued at approximately $60,110,000. Finally, Millennium Management LLC boosted its position in shares of Genpact by 829.4% during the fourth quarter. Millennium Management LLC now owns 1,057,389 shares of the business services provider's stock valued at $45,415,000 after buying an additional 943,622 shares during the period. Hedge funds and other institutional investors own 96.03% of the company's stock.
Wall Street Analysts Forecast Growth
Several research analysts have issued reports on G shares. Robert W. Baird dropped their target price on Genpact from $56.00 to $50.00 and set a "neutral" rating for the company in a research report on Thursday, May 8th. Needham & Company LLC lowered their price target on Genpact from $55.00 to $50.00 and set a "buy" rating for the company in a report on Thursday, May 8th. Mizuho boosted their price target on Genpact from $45.00 to $55.00 and gave the company a "neutral" rating in a report on Monday, February 10th. Finally, Wall Street Zen upgraded Genpact from a "buy" rating to a "strong-buy" rating in a report on Friday. Four research analysts have rated the stock with a hold rating, three have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average target price of $50.71.
Check Out Our Latest Analysis on Genpact
Genpact Stock Up 0.2%
NYSE:G traded up $0.07 during trading hours on Monday, reaching $43.20. The company's stock had a trading volume of 2,395,192 shares, compared to its average volume of 1,381,660. The company has a market capitalization of $7.55 billion, a P/E ratio of 15.21, a price-to-earnings-growth ratio of 1.84 and a beta of 0.94. Genpact Limited has a 12 month low of $30.38 and a 12 month high of $56.76. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.85 and a current ratio of 2.16. The stock has a 50 day moving average price of $45.83 and a two-hundred day moving average price of $47.22.
Genpact (NYSE:G - Get Free Report) last issued its quarterly earnings data on Wednesday, May 7th. The business services provider reported $0.84 EPS for the quarter, topping analysts' consensus estimates of $0.80 by $0.04. The company had revenue of $1.21 billion during the quarter, compared to the consensus estimate of $1.21 billion. Genpact had a net margin of 10.77% and a return on equity of 22.50%. Genpact's revenue for the quarter was up 7.4% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.73 earnings per share. Equities analysts predict that Genpact Limited will post 3.21 EPS for the current fiscal year.
Genpact Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Monday, June 30th. Investors of record on Wednesday, June 18th will be paid a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a yield of 1.57%. The ex-dividend date of this dividend is Wednesday, June 18th. Genpact's dividend payout ratio (DPR) is 23.21%.
Insider Buying and Selling
In other Genpact news, Director Nicholas C. Gangestad purchased 2,000 shares of Genpact stock in a transaction dated Tuesday, May 13th. The shares were acquired at an average cost of $43.97 per share, with a total value of $87,940.00. Following the completion of the transaction, the director now owns 2,000 shares in the company, valued at approximately $87,940. This trade represents a ∞ increase in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CEO Balkrishan Kalra sold 13,600 shares of the company's stock in a transaction on Thursday, March 13th. The stock was sold at an average price of $48.89, for a total value of $664,904.00. Following the transaction, the chief executive officer now directly owns 310,246 shares in the company, valued at approximately $15,167,926.94. The trade was a 4.20% decrease in their ownership of the stock. The disclosure for this sale can be found here. 3.07% of the stock is currently owned by insiders.
Genpact Company Profile
(
Free Report)
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
See Also

Before you consider Genpact, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.
While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report